Inventor · disambiguated record
Christopher Fraser
Also filed as: FRASER CHRISTOPHER · FRASER CHRISTOPHER C · FRASER CHRISTOPHER GEORGE
12 granted patents·12 pending applications·239 citations·filing 2003–2023
94Inventor score
Files withSELECTA BIOSCIENCES INC13FRASER CHRISTOPHER5KISHIMOTO TAKASHI KEI3FRASER CHRISTOPHER GEORGE1LIPFORD GRAYSON B1
Top patents by PatentIndex Score
24 records- 0196US10441651B2Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cellsSELECTA BIOSCIENCES INC·Filed 2015·Granted Oct 15, 2019·16 cites·15 claims
- 0296US10420835B2Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cellsSELECTA BIOSCIENCES INC·Filed 2015·Granted Sep 24, 2019·17 cites·19 claims
- 0396US9987354B2Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cellsFRASER CHRISTOPHER·Filed 2012·Granted Jun 5, 2018·29 cites·16 claims
- 0496US9295718B2Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsFRASER CHRISTOPHER·Filed 2012·Granted Mar 29, 2016·33 cites·14 claims
- 0596US9289476B2Tolerogenic synthetic nanocarriers for allergy therapyKISHIMOTO TAKASHI KEI·Filed 2012·Granted Mar 22, 2016·30 cites·8 claims
- 0696US9289477B2Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responsesFRASER CHRISTOPHER·Filed 2012·Granted Mar 22, 2016·30 cites·12 claims
- 0794US10004802B2Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cellsKISHIMOTO TAKASHI KEI·Filed 2012·Granted Jun 26, 2018·20 cites·18 claims
- 0894US9265815B2Tolerogenic synthetic nanocarriersFRASER CHRISTOPHER·Filed 2012·Granted Feb 23, 2016·50 cites·10 claims
- 0993US11779641B2Tolerogenic synthetic nanocarriers for allergy therapySELECTA BIOSCIENCES INC·Filed 2016·Granted Oct 10, 2023·3 cites·18 claims
- 1092US11717569B2Tolerogenic synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2016·Granted Aug 8, 2023·5 cites·19 claims
- 1190US2024261396A1Tolerogenic synthetic nanocarriers for allergy therapySELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1288US2023321225A1Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1387US2023321224A1Tolerogenic synthetic nanocarriers to reduce antibody responsesSELECTA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1487US2023310593A1Tolerogenic synthetic nanocarriers for allergy therapySELECTA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1586US2024156955A1Tolerogenic synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1681US2020101155A1Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cellsSELECTA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1781US2020101154A1Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cellsSELECTA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1880US8546550B2Immunostimulatory oligonucleotidesLIPFORD GRAYSON B·Filed 2011·Granted Oct 1, 2013·5 cites·27 claims
- 1962US2013059009A1Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriersKISHIMOTO TAKASHI KEI·Filed 2012·Application pending·0 cites
- 2050US2003215442A1Methods and compositions for the treatment or prevention of immune disorders using combination therapyFiled 2003·Application pending·0 cites
- 2141US2016220501A1Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsSELECTA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 2240US7067001B2Drainage composition and uses thereofFRASER CHRISTOPHER GEORGE·Filed 2003·Granted Jun 27, 2006·1 cites·10 claims
- 2338US2012070493A1Targeted multi-epitope dosage forms for induction of an immune response to antigensFRASER CHRISTOPHER·Filed 2011·Application pending·0 cites
- 2436US2011110965A1Compositions that induce t cell helpSELECTA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Fraser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →